Anzu Special Acquisition Corp I, trading under the ticker ANZU, was a blank-check company that completed its initial public offering in 2021 and targeted the healthcare and medical-device sector. The SPAC pursued a business combination with Envoy Medical, Inc., a Minnesota-based company focused on fully implantable hearing devices, most notably its Esteem product. The 10-Q filing dated August 15, 2022, filed under accession number 0001104659-22-091412, reflects the company's reporting obligations during the late stage of the de-SPAC transaction process. Envoy Medical operates in the hearing-health segment of the medical-device industry, a niche area within broader healthcare technology. Sign up for a SpacDesk account to access full filing histories, transaction timelines, and analytics for ANZU and hundreds of other SPAC deals.